Gunderson Dettmer Represented Hims & Hers Health, Inc. in Upsized $1 Billion Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare

Gunderson Dettmer advised Hims & Hers (NYSE: Hims) in its offering of $1 billion aggregate principal amount of 0.00% convertible senior notes due 2030.  This amount includes the exercise in full by the initial purchasers of their option to purchase up to an additional $130 million aggregate principal amount of notes, with the upsize from the originally announced $450 million offering reflecting strong investor demand.

Hims & Hers intends to use proceeds from the offering for general corporate purposes, including accelerating global expansion through both organic growth and strategic acquisitions. The funds will also support the technology team, led by newly appointed CTO Mo Elshenawy, to expand the Company’s data pipeline, develop AI tools, and advance personalized treatments to enhance the consumer healthcare experience. In addition, a portion of the net proceeds was used to fund the cost of entering into certain capped call transactions. 

Morgan Stanley and J.P. Morgan acted as representatives of the initial purchasers. 
 
The Gunderson Dettmer deal team was led by Alexa Belonick and Elena Vespoli, and included Jeff Vetter, Kevin Mann, Mark Mabry, Jaime Narayan, Jay DelMonico, Samuel Willie, and Scott Paraker.

Companies
Hims & Hers
Morgan Stanley
J.P. Morgan

See more Gunderson work here.